Concepedia

Tadeusz Robak

TR

Statistics

Publications

364

Citations

31K

H-Index

72

Active since

1967

Affiliations

Medical University of Lodz(Current)

Copernicus Memorial Hospital

The University of Texas MD Anderson Cancer Center

Medical University of Silesia

Gdańsk Medical University

Tadeusz Robak is an author at Medical University of Lodz specializing in medicine, oncology, and hematologic malignancy therapy.

ORCID

Publications per year

1967–2025

364

Publications

364

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

Michael Hallek, Bruce D. Cheson, Daniel Catovsky et al. · Blood · 2018 · 1.7K citations · Full text

, , +5

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

John C. Byrd, Jennifer R. Brown, Susan O’Brien et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

, , +17

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

, , +11

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

Philippe Moreau, Halyna Pylypenko, Sebastian Grosicki et al. · The Lancet Oncology · 2011 · 917 citations

, , +15

Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

John F. Seymour, Thomas J. Kipps, Barbara Eichhorst et al. · New England Journal of Medicine · 2018 · 909 citations · Full text

, , +13

1–5 of 364